Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Best Design Bloggers for Style Motivation - 2Truly amazing Palaces: Which Is Your Number one?
- 3Iranian president warns of retaliation against Gulf states
- 4Spain's Easter processions draw more tourists amid Iran war
- 5What we know about the 'Stranger Things' spinoff — plus the one cast member who guessed it correctly
- Space station changes command, setting stage for Crew 11 departure
- Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs
- Will your baby get a hep B vaccine? What RFK panel's ruling means.
- December's overlooked meteor shower peaks next week — will the Ursids surprise us?
- A24's 'Backrooms' trailer shows endless fluorescent-lit spaces and terrifying mannequins melting into the floor
- Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- Thermo Fisher wins contracts as pharma shifts production to US, CEO says
- The Magnificence of Extraordinariness: Presenting Valuable Adornments and Gemstones
- Scientists have found an alarming environmental impact of vast data centers
